Overview
What is BenevolentAI?
BenevolentAI is an AI platform that leverages machine learning and data analysis to accelerate drug discovery and development. It aims to transform the pharmaceutical industry by using AI to analyze vast amounts of scientific data and generate novel insights for the discovery of new treatments and therapies....
Leaving a review helps other professionals like you evaluate Machine Learning Tools
Be the first one in your network to review BenevolentAI, and make your voice heard!
Get StartedPricing
Entry-level set up fee?
- No setup fee
Offerings
- Free Trial
- Free/Freemium Version
- Premium Consulting/Integration Services
Would you like us to let the vendor know that you want pricing?
Alternatives Pricing
What is Kimola Cognitive?
Kimola Cognitive is a Machine Learning Platform that enables users to grab reviews from 20+ channels and analyze + classify customer feedback -or any text data- automatically. Top features of Kimola Cognitive are: Scrape Web and Collect Reviews Data analysis starts with data collection, and…
What is Gavagai?
Gavagai Explorer is a text analysis tool for companies that want to keep track of what their customers think – regardless of which language they speak. Explorer analyzes texts in 47 languages. The texts get automatically analyzed and the results are presented in interactive and share-able…
Product Details
- About
- Tech Details
What is BenevolentAI?
BenevolentAI is an AI platform that leverages machine learning and data analysis to accelerate drug discovery and development. It aims to transform the pharmaceutical industry by using AI to analyze vast amounts of scientific data and generate novel insights for the discovery of new treatments and therapies.
Key Features
AI-driven Drug Discovery: BenevolentAI's platform utilizes artificial intelligence and machine learning algorithms to analyze scientific data and identify potential drug candidates.
Data Integration and Analysis: BenevolentAI's platform allows for the integration and analysis of diverse datasets from various sources, enabling comprehensive analysis and interpretation.
Predictive Analytics: BenevolentAI's platform employs predictive analytics to generate insights and predictions about drug efficacy, safety, and potential side effects.
Target Identification and Validation: BenevolentAI's platform assists researchers in identifying and validating potential drug targets by analyzing genetic and molecular data.
Knowledge Graphs and Visualization: BenevolentAI's platform utilizes knowledge graphs and visualization techniques to represent complex relationships and connections between biological entities.
Machine Learning Model Development: BenevolentAI's platform provides tools and capabilities for data scientists to develop and deploy machine learning models specific to drug discovery and analysis.
End-to-End Drug Discovery: BenevolentAI offers end-to-end drug discovery solutions, covering the entire drug discovery and development process.
Knowledge Exploration Tools: BenevolentAI has developed customizable SaaS products for knowledge exploration, including BenAI-Q and BenAI Research Assistant.
Collaborations with AstraZeneca and Merck: BenevolentAI has established collaborations with leading pharmaceutical companies AstraZeneca and Merck to discover and develop novel therapeutics.
In-house Wet Labs: BenevolentAI has fully equipped wet labs in Cambridge, UK, supporting the development and validation of drug candidates identified through the AI-enabled drug discovery platform.
BenevolentAI Technical Details
| Deployment Types | Software as a Service (SaaS), Cloud, or Web-Based |
|---|---|
| Operating Systems | Web-Based |
